139 related articles for article (PubMed ID: 9163730)
1. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
2. DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA1).
Lee ST; Park SK; Lee H; Lee JS; Park YW
Jpn J Hum Genet; 1997 Dec; 42(4):499-505. PubMed ID: 9560949
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
4. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
[TBL] [Abstract][Full Text] [Related]
7. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).
Ghodsinejad Kalahroudi V; Kamalidehghan B; Arasteh Kani A; Aryani O; Tondar M; Ahmadipour F; Chung LY; Houshmand M
PLoS One; 2014; 9(9):e106656. PubMed ID: 25216246
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
King RA; Oetting WS
Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
10. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.
Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C
Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472
[TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
Ko JM; Yang JA; Jeong SY; Kim HJ
Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene.
Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W
Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949
[TBL] [Abstract][Full Text] [Related]
16. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
[TBL] [Abstract][Full Text] [Related]
17. [Human oculocutaneous albinism. From clinical observation to molecular biology].
Aquaron R
Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
[TBL] [Abstract][Full Text] [Related]
18. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
19. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
Giebel LB; Tripathi RK; King RA; Spritz RA
J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
[TBL] [Abstract][Full Text] [Related]
20. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
